#SARS-CoV-2

Using machine learning, researchers find patterns in electronic health record data to better identify those likely to have the condition.

Approximately 1 in 3 Americans 65 and older who completed their initial vaccination round still have not received a first booster shot.

People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.

With further testing, the antiviral proteins might be used as a nasal spray to prevent or treat COVID-19.

Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.

A federal court judge in Florida said the Centers for Disease Control and Prevention had overstepped its authority.

Remdesivir (Veklury) is now approved for kids ages 28 days to 12 years.

Antiviral drugs that target host cells may work against many existing and future variants of the virus that causes COVID-19.

The proportion without symptoms was higher than previously seen in many studies of both people with HIV and the general population.

The diagnostic test can provide results in less than three minutes.

CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.

Could the immune dysfunction that causes severe COVID in people with schizophrenia be what drives their psychotic symptoms?

The quick spread of the BA.2 subvariant is likely due to its greater infectiousness rather than its ability to evade the immune system.

NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.

The benefits of achieving herd immunity thresholds have been less successful with respiratory viruses that continually mutate.

Novel therapies, improved technologies and a better understanding of the immune system could yield broad dividends.